Xenon Pharmaceuticals XENE
NASDAQ XENE
$36.23 -0.04 (-0.11%)
As of: Oct 21, 2026 · 11:36 AM EDT

Xenon Pharmaceuticals (XENE) EV to EBITDA (2014 - 2015)

Updated

Xenon Pharmaceuticals' (XENE) EV to EBITDA stood at 24.96 in Q2 2015, down 28.5% from the prior quarter.

Analysis

Xenon Pharmaceuticals (XENE) EV to EBITDA (2014 - 2015) Analysis & Trends

On a TTM basis, Xenon Pharmaceuticals' EV to EBITDA came in at -32.04 as of Jun 30, 2015; for FY2014, it was -1.82.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Xenon Pharmaceuticals 3.61 Bn 572.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 24.96
Mar 31, 2015 34.93
Dec 31, 2014 -1.82
API Access

Xenon Pharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=XENE&period=max&api_key=YOUR_API_KEY